GlassScriptPhysician profile
Bharat Sharma
NPI 1255795571
$593.94
in general payments reported to CMS, 2019-2025
9 companies · $14.46 in 2025
The $14.46 reported for 2025 was less than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
See the full distribution for Pain Medicine (Anesthesiology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $379 · 2023: $174 · 2024: $27.19 · 2025: $14.46.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $215.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $215.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nevro Corp. | $270.54 | 2022 | |
| Medtronic, INC. | $127.21 | 2022-2025 | Intellis Adaptivestim, Retia Medical |
| Painteq LLC | $51.04 | 2023 | Painteq |
| Spr Therapeutics, INC | $45.00 | 2022 | |
| Heron Therapeutics, INC. | $27.19 | 2024 | Aponvie |
| Vertos Medical, INC. | $20.27 | 2022 | |
| Abbvie INC. | $20.13 | 2023 | Qulipta, Ubrelvy |
| Boston Scientific Corporation | $18.50 | 2022 | |
| Avanos Medical | $14.06 | 2023 | Generator |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bharat Sharma listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.